Insmed (INSM)
(Delayed Data from NSDQ)
$74.50 USD
+0.07 (0.09%)
Updated Jul 25, 2024 04:00 PM ET
After-Market: $74.48 -0.02 (-0.03%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -1.22 |
EPS Last Quarter | -1.06 |
Last EPS Surprise | 13.11% |
ABR | 1.00 |
Earnings ESP
|
7.26% |
---|---|
Current Year | -4.71 |
Next Year | -3.79 |
EPS (TTM) | -5.22 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 87.96M | 92.89M | 353.25M | 530.30M |
# of Estimates | 6 | 6 | 6 | 6 |
High Estimate | 90.00M | 95.00M | 358.98M | 639.00M |
Low Estimate | 86.20M | 91.08M | 349.40M | 451.83M |
Year ago Sales | 77.23M | 79.07M | 305.21M | 353.25M |
Year over Year Growth Est. | 13.89% | 17.48% | 15.74% | 50.12% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.22 | -1.02 | -4.71 | -3.79 |
# of Estimates | 7 | 6 | 9 | 8 |
Most Recent Consensus | -0.50 | -0.51 | -4.26 | -3.36 |
High Estimate | -0.50 | -0.51 | -4.11 | -3.08 |
Low Estimate | -1.88 | -1.26 | -5.46 | -4.67 |
Year ago EPS | -1.78 | -1.10 | -5.34 | -4.71 |
Year over Year Growth Est. | 31.46% | 7.27% | 11.80% | 19.66% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 4 | 4 | 3 | 5 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 1 | 2 | 2 |
Down Last 60 Days | 3 | 2 | 5 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.22 | -1.02 | -4.71 | -3.79 |
7 Days Ago | -1.22 | -1.02 | -4.71 | -3.79 |
30 Days Ago | -1.18 | -1.10 | -4.58 | -3.73 |
60 Days Ago | -1.13 | -1.11 | -4.52 | -3.64 |
90 Days Ago | -1.17 | -1.11 | -4.65 | -3.85 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.13 | -0.97 | -4.80 | -3.75 |
Zacks Consensus Estimate | -1.22 | -1.02 | -4.71 | -3.79 |
Earnings ESP | 7.26% | 4.73% | -1.89% | 1.06% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.06 | -1.28 | -1.10 | -1.78 | NA |
Estimate | -1.22 | -1.13 | -1.06 | -1.10 | NA |
Difference | 0.16 | -0.15 | -0.04 | -0.68 | -0.18 |
Surprise | 13.11% | -13.27% | -3.77% | -61.82% | -16.44% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more